We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPCB.U
151
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
$7.49M 0.04%
+750,000
New +$7.55M
GSEVU
152
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
$7.47M 0.04%
+750,000
New +$7.64M
SLACU
153
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$7.46M 0.04%
+750,000
New +$7.74M
VAQC
154
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$7.42M 0.04%
+750,000
New +$7.47M
PFDRU
155
DELISTED
Pathfinder Acquisition Corporation Unit
PFDRU
$7.42M 0.04%
+750,000
New +$7.62M
TBCPU
156
DELISTED
Thunder Bridge Capital Partners III Inc. Units
TBCPU
$7.42M 0.04%
+750,000
New +$7.67M
CNTB
157
Connect Biopharma Holdings
CNTB
$139M
$7.4M 0.04%
+400,000
New +$6.81M
STRE.U
158
DELISTED
Supernova Partners Acquisition Company III, Ltd. Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
STRE.U
$7M 0.03%
+700,000
New +$6.98M
NXU.U
159
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$7M 0.03%
+700,000
New +$7.31M
FNCH
160
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$6.21M 0.03%
+13,000
New +$6.62M
IMGN
161
DELISTED
Immunogen Inc
IMGN
$6.08M 0.03%
750,000
-250,000
-25% -$2.04M
KVSA
162
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$6.06M 0.03%
+600,000
New +$6.17M
GTPBU
163
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$5.98M 0.03%
+600,000
New +$6.07M
FSRXU
164
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$5.98M 0.03%
+600,000
New +$6.21M
IPVIU
165
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
$5.93M 0.03%
+600,000
New +$5.98M
RXRAU
166
DELISTED
RXR Acquisition Corp. Units
RXRAU
$5.91M 0.03%
+600,000
New +$5.96M
PHVS icon
167
Pharvaris
PHVS
$2.44B
$5.61M 0.03%
+200,000
New +$6.29M
COGT icon
168
Cogent Biosciences
COGT
$7.24B
$5.27M 0.03%
600,000
– –
HARP
169
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$5.23M 0.03%
+25,000
New +$5.01M
TBA
170
DELISTED
Thoma Bravo Advantage
TBA
$5.22M 0.03%
+500,000
New +$5.79M
CGEM icon
171
Cullinan Oncology
CGEM
$1.14B
$5.21M 0.03%
+125,000
New +$5.07M
INNV icon
172
InnovAge Holding
INNV
$1.52B
$5.16M 0.03%
+200,000
New +$4.93M
SRNGU
173
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
$5.06M 0.03%
+500,000
New +$5.21M
AUS.U
174
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$5.02M 0.02%
+500,000
New +$5.08M
SMRT icon
175
SmartRent
SMRT
$272M
$5M 0.02%
+500,000
New +$5.27M
5 6
7
8 9

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.